SULFADIAZINE Drug Patent Profile
✉ Email this page to a colleague
When do Sulfadiazine patents expire, and what generic alternatives are available?
Sulfadiazine is a drug marketed by Abbvie, Chartwell Molecular, Epic Pharma Llc, Everylife, Impax Labs, Lederle, and Lilly. and is included in seven NDAs.
The generic ingredient in SULFADIAZINE is sulfadiazine sodium. There are nineteen drug master file entries for this compound. Additional details are available on the sulfadiazine sodium profile page.
Summary for SULFADIAZINE
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 7 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 137 |
Clinical Trials: | 27 |
Patent Applications: | 5,464 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SULFADIAZINE at DailyMed |
Recent Clinical Trials for SULFADIAZINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Skingenix, Inc. | Phase 2 |
SCARM Institute, Tabriz, Iran | Phase 2 |
Shanghai Yueyang Integrated Medicine Hospital | Phase 2 |
Pharmacology for SULFADIAZINE
Drug Class | Sulfonamide Antibacterial |
Medical Subject Heading (MeSH) Categories for SULFADIAZINE
Anatomical Therapeutic Chemical (ATC) Classes for SULFADIAZINE
US Patents and Regulatory Information for SULFADIAZINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | SULFADIAZINE | sulfadiazine | TABLET;ORAL | 004125-005 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | SULFADIAZINE | sulfadiazine | TABLET;ORAL | 004122-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Everylife | SULFADIAZINE | sulfadiazine | TABLET;ORAL | 080088-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lederle | SULFADIAZINE SODIUM | sulfadiazine sodium | INJECTABLE;INJECTION | 004054-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Chartwell Molecular | SULFADIAZINE | sulfadiazine | TABLET;ORAL | 080084-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Epic Pharma Llc | SULFADIAZINE | sulfadiazine | TABLET;ORAL | 040091-001 | Jul 29, 1994 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lederle | SULFADIAZINE | sulfadiazine | TABLET;ORAL | 004054-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |